MedPage Today January 24, 2025
Joyce Frieden

— “There’s plenty of political will there”

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the waning days of 2024 seems to still be viable for passage this year, according to a House staff member.

“I think there’s plenty of political will there; that’s what I’ve seen from members,” Preston Bell, a professional staff member on the House Ways & Means Committee, said Thursday at an event sponsored by the American Enterprise Institute (AEI) on the future of the Medicare prescription drug benefit. “I do think there are disparate ideas across Congress as to how much intervention within the PBM market is appropriate. What you’ve seen come through Congress in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
U.S. investors, Big Pharma race to find new medicines in China
How Pharma Can Effectively Combat Misinformation/Disinformation
Novartis Strikes Deal to Acquire Anthos Therapeutics
Pharma Pulse 2/13/25: The Transformative Power of Data Analytics, Growing Popularity of Non-hormonal Menopause Therapies & more
Aardvark prices $94M IPO to fund Prader-Willi, obesity drug work

Share This Article